GUFIC BIOSCIENCES
Back to All Ratios
|
GUFIC BIOSCIENCES Last 5 Year Receivable days History
[Consolidated]
Mar2025 | Mar2024 | |
---|---|---|
Receivable days | 106.89 | 128.09 |
What is the latest Receivable days ratio of GUFIC BIOSCIENCES ?
Year | Receivable days |
---|---|
Mar2025 | 106.89 |
Mar2024 | 128.09 |
How is Receivable days of GUFIC BIOSCIENCES Trending?
Years | Receivable days | % Change | |
---|---|---|---|
Mar2025 | 106.89 | -16.55 | |
Mar2024 | 128.09 | - |
Other Financial Ratios of GUFIC BIOSCIENCES
Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare Receivable days ratio of peers of GUFIC BIOSCIENCES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
GUFIC BIOSCIENCES | ₹3,524.0 Cr | -3.7% | -3.3% | -20.6% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹405,140.0 Cr | 2.1% | 2.4% | -11.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹175,290.0 Cr | 0.7% | 8.2% | 8.1% | Stock Analytics | |
CIPLA | ₹132,417.0 Cr | 5.6% | 3.9% | 1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹120,839.0 Cr | 1.5% | 0.1% | 1.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹107,031.0 Cr | 3.7% | -3% | -6.4% | Stock Analytics |
GUFIC BIOSCIENCES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
GUFIC BIOSCIENCES | -3.7% |
-3.3% |
-20.6% |
SENSEX | 2.5% |
2% |
3.1% |
You may also like the below Video Courses